Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Y019157 | IM / LA |
Patient reported mild rash and swelling that extended down arm, appearing approximately 12-18 hours after vaccine and continued for about 3 days before abating. Patient reports no further adverse effects after event. Patient advised to watch for any further signs or symptoms and report as needed.